Table of Contents

What Is Rheumatology?

Rheumatology is the branch of medicine that deals with diseases affecting the joints, muscles, bones, and connective tissues — particularly conditions caused by the immune system attacking the body’s own tissues. If you’ve heard of rheumatoid arthritis, lupus, or gout, you’ve already encountered the kinds of conditions rheumatologists treat. But the specialty covers far more than most people realize — over 200 distinct diseases fall under the rheumatology umbrella.

Rheumatologists are internal medicine physicians who complete an additional 2-3 years of fellowship training specifically in rheumatic diseases. They’re detectives, in a sense. Many of the conditions they diagnose share overlapping symptoms — fatigue, joint pain, inflammation — and sorting out which disease is actually causing the problem often requires careful analysis of symptoms, blood work, imaging, and clinical judgment.

The Scope of Rheumatic Diseases

The numbers are striking. According to the CDC, over 58 million American adults — roughly 24% of the adult population — have some form of arthritis. Worldwide, rheumatic and musculoskeletal diseases affect over 1.7 billion people, making them the leading cause of disability globally, according to the Global Burden of Disease study.

Rheumatic diseases fall into several categories:

Inflammatory Arthritis

This is probably what most people think of when they hear “rheumatology.” Unlike osteoarthritis (which is wear-and-tear degeneration), inflammatory arthritis is driven by the immune system.

Rheumatoid arthritis (RA) affects about 1.3 million Americans. The immune system attacks the synovium — the lining of the joints — causing inflammation, pain, swelling, and eventual joint destruction if untreated. It typically affects the small joints of the hands and feet symmetrically (both sides at once). RA can also attack the eyes, lungs, heart, and blood vessels, making it a systemic disease, not just a joint disease.

Psoriatic arthritis develops in about 30% of people with the skin condition psoriasis. It can affect any joint and ranges from mild to severely destructive. The tricky part is that psoriatic arthritis sometimes appears before any skin symptoms, making diagnosis harder.

Ankylosing spondylitis primarily targets the spine and sacroiliac joints (where the spine meets the pelvis). Over time, chronic inflammation can cause vertebrae to fuse together, severely limiting mobility. It tends to start in the late teens or twenties — much younger than most forms of arthritis.

Gout is caused by the buildup of uric acid crystals in joints, most famously the big toe. A gout attack is extraordinarily painful — patients describe it as feeling like their joint is on fire. Gout affects about 9.2 million Americans and is strongly associated with diet, alcohol consumption, and kidney function. The good news: gout is one of the most treatable rheumatic diseases when managed properly.

Autoimmune Connective Tissue Diseases

These conditions involve the immune system attacking connective tissues throughout the body — not just joints.

Systemic lupus erythematosus (lupus) can affect virtually any organ system. Joints, skin, kidneys, brain, heart, and lungs are all potential targets. Lupus disproportionately affects women (9 out of 10 patients are female), particularly women of color. The disease is notoriously difficult to diagnose because its symptoms mimic many other conditions — earning it the nickname “the great imitator.”

Sjogren’s syndrome attacks the moisture-producing glands, causing severe dry eyes and dry mouth. It often occurs alongside other autoimmune conditions and affects about 1-4 million Americans.

Systemic sclerosis (scleroderma) causes hardening and tightening of the skin and connective tissues. In severe forms, it affects internal organs, particularly the lungs and kidneys. It’s rare but can be devastating.

Vasculitis refers to a group of diseases that cause inflammation of blood vessels. There are over 20 types, ranging from mild skin conditions to life-threatening organ damage.

Crystal-Induced Diseases

Beyond gout, calcium pyrophosphate deposition disease (CPPD, sometimes called “pseudogout”) causes joint inflammation from calcium crystal deposits rather than uric acid. It most commonly affects the knees and wrists.

Osteoporosis

While rheumatologists don’t treat all bone conditions, many manage osteoporosis — the thinning and weakening of bones that affects roughly 10 million Americans and causes over 2 million fractures annually. Osteoporosis is particularly common in postmenopausal women due to declining estrogen levels.

How Rheumatologists Diagnose

Diagnosing rheumatic diseases is genuinely difficult. There’s no single test that definitively confirms most conditions. Instead, rheumatologists piece together evidence from multiple sources.

Blood tests provide crucial clues. Key markers include:

Rheumatoid factor (RF) and anti-CCP antibodies — associated with rheumatoid arthritis
Antinuclear antibodies (ANA) — elevated in lupus and other autoimmune conditions
Erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) — general markers of inflammation
Uric acid levels — relevant for gout diagnosis
HLA-B27 — a genetic marker associated with ankylosing spondylitis

But here’s the catch: these tests are suggestive, not definitive. A positive ANA appears in about 15% of healthy people. Rheumatoid factor can be positive in people without RA. And some patients with confirmed rheumatic diseases have perfectly normal blood work. This is why clinical expertise — the doctor’s ability to interpret test results alongside symptoms, physical findings, and patient history — matters so much in this specialty.

Imaging adds another layer. X-rays show bone erosion and joint space narrowing. MRI reveals soft tissue inflammation, including synovitis and bone marrow edema that X-rays miss. Ultrasound is now more popular in rheumatology offices because it can detect joint inflammation in real time during the examination.

Joint aspiration — drawing fluid from an inflamed joint with a needle — is definitive for crystal diseases. Under a polarized light microscope, monosodium urate crystals (gout) look needle-shaped, while calcium pyrophosphate crystals (pseudogout) appear rhomboid. This is one of the few truly “gold standard” diagnostic tests in rheumatology.

Treatment Approaches

Rheumatology treatment has been transformed over the past 25 years. The old approach — wait and see, manage pain, accept gradual disability — has been replaced by early, aggressive intervention aimed at controlling disease before it causes permanent damage.

Conventional DMARDs

Disease-modifying antirheumatic drugs (DMARDs) slow or stop the progression of inflammatory diseases. Methotrexate, introduced for RA in the 1980s, remains the first-line treatment and the standard against which newer drugs are measured. It’s remarkably effective for a drug that costs about $20 per month — reducing joint damage, inflammation, and disability in most patients.

Other conventional DMARDs include sulfasalazine, hydroxychloroquine (yes, the drug that made headlines during COVID-19 — it’s been used for lupus and RA for decades), and leflunomide.

Biologic Therapies

The real game-changer arrived in 1998 with the approval of etanercept (Enbrel), the first biologic DMARD. Biologics are engineered proteins that target specific components of the immune system — particularly TNF-alpha, interleukins, and B-cells — that drive inflammation.

The results can be dramatic. Patients who weren’t responding to methotrexate sometimes achieve near-complete disease control on biologics. Joint damage that was previously considered inevitable can be prevented or significantly slowed.

The downside: biologics are expensive. A year’s supply can cost $20,000 to $70,000 without insurance. They also suppress the immune system, increasing infection risk. And they require administration by injection or IV infusion rather than simple oral dosing.

As of 2024, there are over 20 FDA-approved biologic and targeted synthetic DMARDs, with more in development. The field is moving fast.

JAK Inhibitors

The newest class, Janus kinase (JAK) inhibitors — tofacitinib (Xeljanz), baricitinib (Olumiant), and upadacitinib (Rinvoq) — are oral medications that block intracellular signaling pathways involved in inflammation. They offer biologic-like effectiveness in pill form. However, FDA safety reviews have raised concerns about cardiovascular events and cancer risk in certain populations, so their use is typically reserved for patients who haven’t responded to other treatments.

The Rheumatologist Shortage

Here’s an uncomfortable reality: there aren’t enough rheumatologists. The American College of Rheumatology estimates there are about 5,500 practicing adult rheumatologists in the United States — one for every roughly 60,000 adults. In rural areas, the ratio is far worse. Many patients wait 3-6 months for an initial appointment, and that delay can mean irreversible joint damage for conditions like RA.

The shortage exists because the training pipeline is long (3 years of internal medicine residency plus 2-3 years of fellowship), the conditions are complex and time-intensive, and reimbursement rates are lower than many other specialties. Efforts to address the gap include expanding fellowship positions, using telemedicine, and training primary care physicians to identify and initiate treatment for common rheumatic conditions.

Living With Rheumatic Disease

Chronic illness is hard. Rheumatic diseases add specific challenges: unpredictable flares, fatigue that goes beyond normal tiredness, visible joint deformity, and the invisible burden of chronic pain. Many patients look healthy on the outside while dealing with significant disability.

Self-management strategies that research supports include regular low-impact exercise (swimming, walking, cycling), maintaining a healthy weight to reduce joint stress, physical and occupational therapy, adequate sleep, and stress management. Smoking cessation is particularly important — smoking worsens RA and reduces treatment effectiveness.

The mental health dimension is significant. Depression affects roughly 20% of RA patients and up to 40% of lupus patients. Rheumatologists increasingly recognize that treating the disease without addressing its psychological impact leaves patients only partially cared for.

The Outlook

Rheumatology is a field being reshaped by science at remarkable speed. Twenty-five years ago, an RA diagnosis often meant progressive disability. Today, most patients diagnosed early and treated aggressively maintain normal or near-normal function. The goal has shifted from managing decline to achieving remission.

The future looks promising. Personalized medicine — using genetic markers and biomarkers to predict which treatment will work best for each individual patient — is moving from theory to practice. New drug targets are being identified. And our understanding of why the immune system turns against itself is deeper than it’s ever been, even if the full picture remains incomplete.

For now, the most important thing anyone with persistent joint pain, unexplained inflammation, or suspected autoimmune symptoms can do is get to a rheumatologist. Early. The difference between treatment at 3 months and treatment at 12 months can be the difference between preservation and permanent damage. That window matters more than almost anything else.

Frequently Asked Questions

When should you see a rheumatologist?

You should see a rheumatologist if you have persistent joint pain, swelling, or stiffness lasting more than a few weeks, especially if it affects multiple joints. Other warning signs include morning stiffness lasting more than 30 minutes, unexplained fatigue combined with joint symptoms, a family history of autoimmune disease, or abnormal blood work showing elevated inflammatory markers. Your primary care doctor can refer you, and early evaluation is critical because many rheumatic diseases cause less damage when treated early.

What is the difference between a rheumatologist and an orthopedist?

Rheumatologists are internal medicine specialists who treat autoimmune and inflammatory conditions with medications. Orthopedists are surgeons who treat bones, joints, and muscles primarily through surgical intervention and physical rehabilitation. If your joint problem is caused by inflammation or an immune system disorder, you will likely see a rheumatologist. If you need a joint replacement or have a fracture, you see an orthopedist. Many patients with conditions like rheumatoid arthritis eventually see both.

Can rheumatic diseases be cured?

Most rheumatic diseases cannot be cured, but many can be effectively managed with current treatments. Medications like disease-modifying antirheumatic drugs (DMARDs) and biologics can slow disease progression, reduce inflammation, and prevent joint damage. Some conditions, like gout, can be controlled to the point where flare-ups rarely occur. Early diagnosis and treatment consistently lead to better long-term outcomes.

What does a rheumatologist do during a first visit?

A first rheumatology appointment typically lasts 45 to 60 minutes. The doctor reviews your medical history and symptoms in detail, performs a physical examination focusing on joints, skin, and other affected areas, and orders blood tests (including inflammatory markers, autoantibodies, and sometimes imaging like X-rays or MRI). Based on these findings, the rheumatologist either makes a diagnosis or schedules follow-up tests to narrow down the condition.